Searchable abstracts of presentations at key conferences in endocrinology

ea0011oc8 | Signal transduction OC1 Novartis Oncology Young Investigator Award | ECE2006

Role of the calcium-calmodulin dependent kinase II in oncogenic Ras-induced proliferation

Cavallo AL , Illario M , Di Vito E , Monaco S , Fenzi G , Rossi G , Vitale M

Activation of the Ras/ERK pathway and stimulation of proliferation by integrins in thyroid cells requires CaMKII activation. To date, whether this role of CaMKII is a general mechanism or is restricted to integrin signalling is unknown. As oncogenic activation of the Ras/ERK pathway by mutated Ras, RET/PTC and Trk is frequent in papillary thyroid carcinoma (PTC), we investigated the expression and activation level of CaMKII in PTC primary culture and in stable cell lines.<...

ea0029oc18.6 | Paediatric Endocrinology | ICEECE2012

The Young Investigator Winner

Nettore I. , Mirra P. , Ferrara A. , Sibilio A. , Kamoi Kay C. , Lorenzoni P. , Werneck L. , Bruck I. , Bequinot F. , Ungaro P. , Fenzi G. , Scola R. , Macchia P.

TTF1/NKX2.1 is a transcription factor expressed in thyroid, lung and brain. Several heterozygous mutations have been described in patients with primary congenital hypothyroidism, respiratory distress and benign hereditary chorea, typical aspects of the ‘thyroid–lung–brain syndrome’.We recently studied a family affected by some of these features, and the direct sequencing of the NKX2.1 gene demonstrated an heterozygous deletion of a cy...